Rehabilitative treatments capable of promoting neuroplasticity such as CE are believed to have therapeutic potential for stroke recovery, especially during the early post-injury, stages when the brain may be highly responsive to treatment.1 This study is the first to examine the effects of CE on BDNF levels in individuals with early subacute stroke. The gene discussed is BDNF; the disease is stroke disorder.